XPhyto Therapeutics rapidly advances its drug delivery system for Parkinson's skin patches
XPhyto Therapeutics Corp (CSE:XPHY) (OTCPINK:XPHYF) offered investors an update on its transdermal delivery system for the neurologic drug Rotigotine saying the “formula was locked” and the company is looking forward to clinical studies in the third quarter of 2020.
Vancouver-based XPhyto Therapeutics first revealed in June that its German subsidiary Vektor Pharma TF GmbH had finalized the formula for its skin patch to help Parkinson’s disease sufferers ahead of human pilot studies.
According to the company, Vektor Pharma has now completed process implementation for the manufacture of its Rotigotine patches. “With process implementation complete, clinical sample manufacturing and analytical work will commence in Vektor’s EU GMP laboratory and manufacturing facility based in Baden-Württemberg, Germany,” it said.
READ: XPhyto Therapeutics expedites development of 5-minute coronavirus saliva test in Germany
XPhyto said human bioavailability studies will take place in Europe during the third quarter, with a data read-out expected by the fourth quarter of this year.
“Our goal is the commercialization of a low-cost Rotigotine patch with superior bioavailability and adhesion properties,” XPhyto Therapeutics CEO Hugh Rogers said in a statement.
“Incorporating Rotigotine into Vektor’s novel transdermal drug delivery system platform is a major accomplishment. With the formula locked and manufacturing soon to commence, we look forward to the upcoming clinical studies,” he added.
Rotigotine is approved for the treatment of Parkinson’s disease and restless legs syndrome in Europe and the United States. The active pharmaceutical ingredient is a generic off-patent drug that is typically formulated as a once-daily skin patch which provides a slow and constant supply of the drug over the course of 24 hours.
Global and European sales of Rotigotine patches last year came in at around $500 million, XPhyto noted.
Contact the author Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive
Story by ProactiveInvestors
Source: https://www.proactiveinvestors.com/companies/news/927475/xphyto-therapeutics-rapidly-advances-its-drug-delivery-system-for-parkinson-s-skin-patches-927475.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).